Global Rotary-Cutting Biopsy System for Breast Lesion Market Growth 2024-2030

Global Rotary-Cutting Biopsy System for Breast Lesion Market Growth 2024-2030

Rotary-Cutting Biopsy System for Breast Lesion s a medical device used for breast tissue biopsy. The device uses vacuum-assisted breast biopsy (VABB) technology. VABB is a safe and efficient procedure for the diagnosis and management of indeterminate and suspicious breast lesions. It provides an adequate amount of tissue, which can help in upgrading or downgrading histopathologically diagnosed patients, thereby decreasing the need for surgery.

The global Rotary-Cutting Biopsy System for Breast Lesion market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Rotary-Cutting Biopsy System for Breast Lesion Industry Forecast” looks at past sales and reviews total world Rotary-Cutting Biopsy System for Breast Lesion sales in 2023, providing a comprehensive analysis by region and market sector of projected Rotary-Cutting Biopsy System for Breast Lesion sales for 2024 through 2030. With Rotary-Cutting Biopsy System for Breast Lesion sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rotary-Cutting Biopsy System for Breast Lesion industry.

This Insight Report provides a comprehensive analysis of the global Rotary-Cutting Biopsy System for Breast Lesion landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rotary-Cutting Biopsy System for Breast Lesion portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rotary-Cutting Biopsy System for Breast Lesion market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rotary-Cutting Biopsy System for Breast Lesion and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rotary-Cutting Biopsy System for Breast Lesion.

United States market for Rotary-Cutting Biopsy System for Breast Lesion is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Rotary-Cutting Biopsy System for Breast Lesion is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Rotary-Cutting Biopsy System for Breast Lesion is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Rotary-Cutting Biopsy System for Breast Lesion players cover Mammotome, SenoRx (BD), Hologic, Chongqing Xishan, GMT Medical, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Rotary-Cutting Biopsy System for Breast Lesion market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
<9G
9-12G
>12G

Segmentation by Application:
Hospital
Diagnostic Center
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Mammotome
SenoRx (BD)
Hologic
Chongqing Xishan
GMT Medical
Cultivate Medical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Rotary-Cutting Biopsy System for Breast Lesion market?

What factors are driving Rotary-Cutting Biopsy System for Breast Lesion market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Rotary-Cutting Biopsy System for Breast Lesion market opportunities vary by end market size?

How does Rotary-Cutting Biopsy System for Breast Lesion break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.